Core Viewpoint - Si-Bone (SIBN) shares have increased by 27.6% in the past four weeks, closing at $18.38, with a mean price target of $24.67 indicating a potential upside of 34.2% [1] Price Targets and Analyst Estimates - The mean estimate consists of nine short-term price targets with a standard deviation of $3.57, where the lowest estimate is $19 (3.4% increase) and the highest is $32 (74.1% increase) [2] - A low standard deviation suggests a high degree of agreement among analysts regarding the stock's price movement [9] Earnings Estimates and Market Sentiment - Analysts are optimistic about SIBN's earnings prospects, as indicated by a positive trend in earnings estimate revisions, with five estimates moving higher and no negative revisions in the last 30 days, resulting in a 7.7% increase in the Zacks Consensus Estimate [11][12] - SIBN holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13]

Group 1 - The stock of Pediatrix Medical Group (MD) closed at $13.56, reflecting a 10.7% gain over the past four weeks, with a mean price target of $17.14 indicating a potential upside of 26.4% [1] - The mean estimate consists of seven short-term price targets with a standard deviation of $2.61, where the lowest estimate is $14 (3.2% increase) and the highest is $21 (54.9% increase) [2] - Analysts show strong agreement on the company's ability to report better earnings than previously predicted, which supports the view of potential upside [4][11] Group 2 - The Zacks Consensus Estimate for the current year has increased by 1.1% over the past month, with two estimates revised higher and no negative revisions [12] - MD holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, indicating strong potential for near-term upside [13] - While the consensus price target may not be entirely reliable, the direction it implies appears to be a good guide for potential price movement [13]

Core Viewpoint - P3 Health Partners Inc. (PIII) is experiencing significant selling pressure, having declined 18.4% over the past four weeks, but is now positioned for a potential trend reversal as it is in oversold territory and analysts expect better earnings than previously predicted [1]. Group 1: Technical Analysis - The Relative Strength Index (RSI) is a key indicator used to determine if a stock is oversold, with a reading below 30 typically indicating this condition [2]. - PIII's current RSI reading is 23.11, suggesting that the heavy selling pressure may be exhausting itself, indicating a potential trend reversal [5]. Group 2: Fundamental Analysis - There is strong consensus among sell-side analysts that earnings estimates for PIII have increased by 7.8% over the last 30 days, which often correlates with price appreciation [7]. - PIII holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate revisions and EPS surprises, further supporting the potential for a turnaround [8].

Core Viewpoint - Nerdy Inc. (NRDY) has been upgraded to a Zacks Rank 2 (Buy), indicating a positive outlook on its earnings estimates, which is a significant factor influencing stock prices [1][3]. Earnings Estimates and Stock Price Impact - The Zacks rating system emphasizes the importance of earnings estimate revisions, which are strongly correlated with near-term stock price movements [4][6]. - An increase in earnings estimates typically leads to higher fair value calculations by institutional investors, resulting in stock price movements [4]. Recent Performance and Projections - For the fiscal year ending December 2025, Nerdy is expected to earn -$0.33 per share, reflecting a 13.2% change from the previous year [8]. - Over the past three months, the Zacks Consensus Estimate for Nerdy has increased by 20.8%, indicating a positive trend in earnings expectations [8]. Zacks Rating System - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with only the top 20% receiving a 'Strong Buy' or 'Buy' rating [9][10]. - The upgrade of Nerdy to a Zacks Rank 2 places it in the top 20% of Zacks-covered stocks, suggesting potential for market-beating returns in the near term [10].

Core Viewpoint - ZipRecruiter, Inc. (ZIP) has seen a 5.3% increase in share price over the past four weeks, closing at $5.59, with analysts suggesting a potential upside of 43.1% based on a mean price target of $8 [1] Price Targets and Analyst Estimates - The mean estimate consists of five short-term price targets with a standard deviation of $1.87, indicating variability among analysts; the lowest estimate is $6 (7.3% increase), while the highest is $10 (78.9% increase) [2] - A low standard deviation suggests a strong agreement among analysts regarding the stock's price movement direction, which can serve as a starting point for further research [9] Earnings Estimates and Analyst Optimism - Analysts show strong agreement in revising earnings per share (EPS) estimates higher, which correlates with potential stock price increases; the Zacks Consensus Estimate for the current year has risen by 1.1% over the past month [4][11][12] - ZipRecruiter holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, indicating a strong potential upside [13]

Core Viewpoint - Vigil Neuroscience, Inc. (VIGL) has seen a significant stock price increase of 340.2% over the past four weeks, closing at $7.88, with a potential upside indicated by Wall Street analysts' mean price target of $14.71, suggesting an 86.7% increase from the current price [1] Price Targets and Analyst Estimates - The mean price target is based on seven short-term estimates with a standard deviation of $4.75, indicating variability among analysts; the lowest estimate is $8 (1.5% increase), while the highest is $22 (179.2% increase) [2] - A low standard deviation among price targets suggests a high degree of agreement among analysts regarding the stock's price movement direction [9] Earnings Estimates and Market Sentiment - Analysts have shown increasing optimism about VIGL's earnings prospects, with a strong consensus on higher EPS estimates, which correlates with potential stock price increases [11] - Over the last 30 days, three earnings estimates have been revised upward, leading to a 6.9% increase in the Zacks Consensus Estimate for the current year [12] Zacks Rank and Investment Potential - VIGL holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, indicating a strong potential for upside in the near term [13]

Group 1 - Birkenstock (BIRK) shares have increased by 9.6% over the past four weeks, closing at $55.05, with a mean price target of $68.88 indicating a potential upside of 25.1% [1] - The average of 17 short-term price targets ranges from a low of $57 to a high of $81, with a standard deviation of $7.34, suggesting a relatively high agreement among analysts [2] - Analysts have shown increasing optimism regarding BIRK's earnings prospects, as indicated by a positive trend in earnings estimate revisions, which historically correlates with stock price movements [4][11] Group 2 - The Zacks Consensus Estimate for BIRK's current year earnings has risen by 3.4% over the past month, with seven estimates increasing and two decreasing [12] - BIRK holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, indicating strong potential for upside [13] - While price targets may not be entirely reliable, the direction they imply appears to be a good guide for potential price movement [13]

Group 1: Stock Performance and Price Targets - Shares of Five9 (FIVN) have increased by 9.5% over the past four weeks, closing at $26.96, with a mean price target of $37.05 indicating a potential upside of 37.4% [1] - The average of 20 short-term price targets ranges from a low of $23 to a high of $65, with a standard deviation of $9.91, suggesting variability in analyst estimates [2] - The lowest estimate indicates a decline of 14.7% from the current price, while the most optimistic estimate suggests a 141.1% upside [2] Group 2: Analyst Consensus and Earnings Estimates - Analysts show strong agreement in revising earnings estimates higher, which is a positive indicator for potential stock upside [4][11] - The Zacks Consensus Estimate for the current year has increased by 47.7% over the past month, with 11 estimates going higher and no negative revisions [12] - FIVN holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13]

Shares of Waystar Holding (WAY) have gained 2.5% over the past four weeks to close the last trading session at $38.20, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $48.60 indicates a potential upside of 27.2%.The mean estimate comprises 10 short-term price targets with a standard deviation of $2.46. While the lowest estimate of $45 indicates a 17.8% increase from the current ...

Group 1 - Upbound Group (UPBD) shares have increased by 16% in the past four weeks, closing at $23.66, with a mean price target of $36.63 indicating a potential upside of 54.8% [1] - The mean estimate consists of eight short-term price targets with a standard deviation of $8.07, where the lowest estimate is $26 (9.9% increase) and the highest is $50 (111.3% increase) [2] - Analysts show strong agreement in revising UPBD's earnings estimates higher, which correlates with potential stock price increases [4][11] Group 2 - The Zacks Consensus Estimate for UPBD's current year has risen by 1.7% over the past month, with three estimates increasing and no negative revisions [12] - UPBD holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] - While consensus price targets may not be reliable for predicting exact stock gains, they can indicate the direction of price movement [13]